单细胞RNA测序表征CD31+胶质瘤细胞的免疫通讯和铁代谢作用。

IF 1.7 4区 医学 Q4 ONCOLOGY
Translational cancer research Pub Date : 2025-04-30 Epub Date: 2025-04-25 DOI:10.21037/tcr-2025-377
Yiming Guan, Yu Luan, Shanshan Zhao, Meiyan Li, Francesco Girolamo, Joshua D Palmer, Qi Guan
{"title":"单细胞RNA测序表征CD31+胶质瘤细胞的免疫通讯和铁代谢作用。","authors":"Yiming Guan, Yu Luan, Shanshan Zhao, Meiyan Li, Francesco Girolamo, Joshua D Palmer, Qi Guan","doi":"10.21037/tcr-2025-377","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gliomas are aggressive brain tumors marked by complex cellular interactions and significant immune cell infiltration. This study investigated the role of CD31<sup>+</sup> immune cells, specifically macrophages and T cells, in the glioma microenvironment through single-cell RNA sequencing (scRNA-seq).</p><p><strong>Methods: </strong>We employed the CellChat framework to map cell-cell communication pathways and used Monocle3 for pseudotime trajectory analysis to characterize the signaling and developmental progressions within CD31<sup>+</sup> cells. Pathways such as osteopontin (SPP1) and major histocompatibility complex class II (MHC-II) were analyzed in terms of their role in immune regulation, and we examined the expression of ferritin, an iron-binding protein, to assess its potential function in modulating CD31<sup>+</sup> cell activity.</p><p><strong>Results: </strong>Our findings highlight the expression of key pathways, including SPP1 and MHC-II, influencing immune regulation. Ferritin was found to be highly expressed in CD31<sup>+</sup> cells, suggesting a dual role in iron metabolism and immune modulation within the glioma microenvironment.</p><p><strong>Conclusions: </strong>This study clarified the distinct roles of CD31<sup>+</sup> immune cells in glioma progression and identified ferritin as a potential therapeutic target for modulating immune responses in gliomas. These findings may offer new directions in glioma research and the development of immunotherapy, which can aid in improving treatment outcomes.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 4","pages":"2421-2439"},"PeriodicalIF":1.7000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079608/pdf/","citationCount":"0","resultStr":"{\"title\":\"Single-cell RNA sequencing for characterizing the immune communication and iron metabolism roles in CD31<sup>+</sup> glioma cells.\",\"authors\":\"Yiming Guan, Yu Luan, Shanshan Zhao, Meiyan Li, Francesco Girolamo, Joshua D Palmer, Qi Guan\",\"doi\":\"10.21037/tcr-2025-377\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Gliomas are aggressive brain tumors marked by complex cellular interactions and significant immune cell infiltration. This study investigated the role of CD31<sup>+</sup> immune cells, specifically macrophages and T cells, in the glioma microenvironment through single-cell RNA sequencing (scRNA-seq).</p><p><strong>Methods: </strong>We employed the CellChat framework to map cell-cell communication pathways and used Monocle3 for pseudotime trajectory analysis to characterize the signaling and developmental progressions within CD31<sup>+</sup> cells. Pathways such as osteopontin (SPP1) and major histocompatibility complex class II (MHC-II) were analyzed in terms of their role in immune regulation, and we examined the expression of ferritin, an iron-binding protein, to assess its potential function in modulating CD31<sup>+</sup> cell activity.</p><p><strong>Results: </strong>Our findings highlight the expression of key pathways, including SPP1 and MHC-II, influencing immune regulation. Ferritin was found to be highly expressed in CD31<sup>+</sup> cells, suggesting a dual role in iron metabolism and immune modulation within the glioma microenvironment.</p><p><strong>Conclusions: </strong>This study clarified the distinct roles of CD31<sup>+</sup> immune cells in glioma progression and identified ferritin as a potential therapeutic target for modulating immune responses in gliomas. These findings may offer new directions in glioma research and the development of immunotherapy, which can aid in improving treatment outcomes.</p>\",\"PeriodicalId\":23216,\"journal\":{\"name\":\"Translational cancer research\",\"volume\":\"14 4\",\"pages\":\"2421-2439\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079608/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/tcr-2025-377\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2025-377","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/25 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:胶质瘤是侵袭性脑肿瘤,其特征是复杂的细胞相互作用和显著的免疫细胞浸润。本研究通过单细胞RNA测序(scRNA-seq)研究了CD31+免疫细胞,特别是巨噬细胞和T细胞在胶质瘤微环境中的作用。方法:我们使用CellChat框架绘制细胞-细胞通信通路,并使用Monocle3进行伪时间轨迹分析,以表征CD31+细胞内的信号传导和发育过程。我们分析了骨桥蛋白(SPP1)和主要组织相容性复合体II类(MHC-II)等通路在免疫调节中的作用,并检测了铁蛋白(一种铁结合蛋白)的表达,以评估其在调节CD31+细胞活性方面的潜在功能。结果:我们的研究结果突出了SPP1和MHC-II等关键通路的表达影响免疫调节。铁蛋白在CD31+细胞中高表达,提示在胶质瘤微环境中铁代谢和免疫调节中具有双重作用。结论:本研究阐明了CD31+免疫细胞在胶质瘤进展中的独特作用,并确定了铁蛋白是调节胶质瘤免疫反应的潜在治疗靶点。这些发现可能为胶质瘤研究和免疫治疗的发展提供新的方向,有助于改善治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Single-cell RNA sequencing for characterizing the immune communication and iron metabolism roles in CD31+ glioma cells.

Background: Gliomas are aggressive brain tumors marked by complex cellular interactions and significant immune cell infiltration. This study investigated the role of CD31+ immune cells, specifically macrophages and T cells, in the glioma microenvironment through single-cell RNA sequencing (scRNA-seq).

Methods: We employed the CellChat framework to map cell-cell communication pathways and used Monocle3 for pseudotime trajectory analysis to characterize the signaling and developmental progressions within CD31+ cells. Pathways such as osteopontin (SPP1) and major histocompatibility complex class II (MHC-II) were analyzed in terms of their role in immune regulation, and we examined the expression of ferritin, an iron-binding protein, to assess its potential function in modulating CD31+ cell activity.

Results: Our findings highlight the expression of key pathways, including SPP1 and MHC-II, influencing immune regulation. Ferritin was found to be highly expressed in CD31+ cells, suggesting a dual role in iron metabolism and immune modulation within the glioma microenvironment.

Conclusions: This study clarified the distinct roles of CD31+ immune cells in glioma progression and identified ferritin as a potential therapeutic target for modulating immune responses in gliomas. These findings may offer new directions in glioma research and the development of immunotherapy, which can aid in improving treatment outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信